In this Issue
- Dan Crenshaw and Elon Musk Add Fuel to Lykos ‘Dumpster Fire’ Drama
- ‘They Not Like Us’ — Psychedelic Drug Developers Emphasise Avoidance of Lykos’ Perceived Pitfalls
- atai Life Sciences
- Beckley Psytech
- Compass Pathways
- MindMed
- Mini Interview: Joshua Ismin, Psylo
- Other Stories
***
It’s been another testy week in the admittedly nebulous psychedelic ‘community’, as those in favour of FDA approval of Lykos Therapeutics’ MDMA-assisted therapy for PTSD find their voices elevated by some significant public figures.
Over the weekend, Republican Dan Crenshaw took a break from advertising Endex Fitness, his company that sells ‘the worlds [sic] first integrated modular conceal carry holster pants & shorts’, to take aim at Lykos’ critics.
In a ~2 minute video-assisted tweet, Crenshaw railed against both ICER and Psymposia, arguing that the former “influenced” the FDA Advisory Committee that voted against the intervention. “These technocrats think they know better than scientists”, he wrote, adding that “Their job is to say NO and support the status quo that makes Big Healthcare plenty of money”. “But there’s hope”, Crenshaw’s tweet continued. “These groups aren’t the FDA”, he said, adding that “We must support the science and push past these activist groups.”
Sign-in or join Pα+ to continue reading…
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.
Already a member? Log In
✓ Regular Bulletins covering key topics and trends in the psychedelics space
✓ Regular articles and deep dives across psychedelic research, policy and business
✓ Interviews with insiders
✓ Monthly interactive database and commentary on psychedelic patents
✓ Quick-take analysis of major developments
✓ A Library of primers and explainers
✓ Access to our full back catalogue